Genetic and environmental factors in complex neurodevelopmental disorders

Current Genomics

Volumn 8, Issue 7, 2007, Pages 429-444

  van Loo, K M J ^a   Martens, G J M ^a  

^a RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

Author keywords

Association studies; Environmental factors; Gene environment interactions; Linkage analysis; Neurodevelopmental disorders; Susceptibility genes

Indexed keywords

MESSENGER RNA;

ADDICTION; ALCOHOLISM; ANXIETY DISORDER; ASPERGER SYNDROME; ATR X SYNDROME; ATTENTION DEFICIT DISORDER; AUTISM; BARTH SYNDROME; BIPOLAR DISORDER; CHROMOSOME ANALYSIS; DEPRESSION; DIGEORGE SYNDROME; DOWN SYNDROME; DYSLEXIA; EATING DISORDER; ENVIRONMENTAL FACTOR; EPIGENETICS; EPILEPSY; FETAL ALCOHOL SYNDROME; FRAGILE X SYNDROME; GENE LOCUS; GENE REPLICATION; GENETIC ASSOCIATION; GENETIC DISORDER; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; GENOME ANALYSIS; GILLES DE LA TOURETTE SYNDROME; HEREDITY; HUMAN; HYDROCEPHALUS; ICF SYNDROME; MANIA; MENTAL DEFICIENCY; NEURODEVELOPMENTAL DISORDER; NEUROFIBROMATOSIS; NEUROLOGIC DISEASE; NONHUMAN; OBSESSIVE COMPULSIVE DISORDER; PANIC; POSTTRAUMATIC STRESS DISORDER; PRADER WILLI SYNDROME; RETT SYNDROME; REVIEW; SCHIZOPHRENIA; SMITH LEMLI OPITZ SYNDROME; SMITH MAGENIS SYNDROME; SPINA BIFIDA; WILLIAM BEUREN SYNDROME;

EID: 41749125456     PISSN: 13892029     EISSN: None     Source Type: Journal    
DOI: 10.2174/138920207783591717     Document Type: Review

References (216)

1. Risch, N., Merikangas, K. The future of genetic studies of complex human diseases. Science 1996, 273: 1516-7.
2. Craddock, N., Owen, M.J. Modern molecular genetic approaches to psychiatric disease. Br. Med. Bull. 1996, 52: 434-52.
3. Owen, M.J., Craddock, N. Modern molecular genetic approaches to complex traits: implications for psychiatric disorders. Mol. Psychiatry 1996, 1: 21-6.
4. Risch, N.J. Searching for genetic determinants in the new millennium. Nature 2000, 405: 847-56.
5. Lee, J.A., Lupski, J.R. Genomic rearrangements and gene copy-number alterations as a cause of nervous system disorders. Neuron 2006, 52: 103-21.
6. Redon, R., Ishikawa, S., Fitch, K.R., Feuk, L., Perry, G.H., Andrews, T.D., Fiegler, H., Shapero, M.H., Carson, A.R., Chen, W., Cho, E.K., Dallaire, S., Freeman, J.L., Gonzalez, J.R., Gratacos, M., Huang, J., Kalaitzopoulos, D., Komura, D., MacDonald, J.R., Marshall, C.R., Mei, R., Montgomery, L., Nishimura, K., Okamura, K., Shen, F., Somerville, M.J., Tchinda, J., Valsesia, A., Woodwark, C., Yang, F., Zhang, J., Zerjal, T., Zhang, J., Armengol, L., Conrad, D.F., Estivill, X., Tyler-Smith, C., Carter, N.P., Aburatani, H., Lee, C., Jones, K.W., Scherer, S.W., Hurles, M.E. Global variation in copy number in the human genome. Nature 2006, 444: 444-54.
7. Tkachev, D., Mimmack, M.L., Ryan, M.M., Wayland, M., Freeman, T., Jones, P.B., Starkey, M., Webster, M.J., Yolken, R.H., Bahn, S. Oligodendrocyte dysfunction in schizophrenia and bipolar disorder. Lancet 2003, 362: 798-805.
8. Montes, G., Halterman, J.S. Characteristics of school-age children with autism. J. Dev. Behav. Pediatr. 2006, 27: 379-85.
9. Freitag, C.M. The genetics of autistic disorders and its clinical relevance: a review of the literature. Mol. Psychiatry 2007, 12: 2-22.
10. Yang, M.S., Gill, M. A review of gene linkage, association and expression studies in autism and an assessment of convergent evidence. Int. J. Dev. Neurosci. 2007, 25: 69-85.
11. Lauritsen, M.B., Als, T.D., Dahl, H.A., Flint, T.J., Wang, A.G., Vang, M., Kruse, T.A., Ewald, H., Mors, O. A genome-wide search for alleles and haplotypes associated with autism and related pervasive developmental disorders on the Faroe Islands. Mol. Psychiatry 2006, 11: 37-46.
12. Szatmari, P., Paterson, A.D., Zwaigenbaum, L., Roberts, W., Brian, J., Liu, X.Q., Vincent, J.B., Skaug, J.L., Thompson, A.P., Senman, L., Feuk, L., Qian, C., Bryson, S.E., Jones, M.B., Marshall, C.R., Scherer, S.W., Vieland, V.J., Bartlett, C., Mangin, L.V., Goedken, R., Segre, A., Pericak-Vance, M.A., Cuccaro, M.L., Gilbert, J.R., Wright, H.H., Abramson, R.K., Betancur, C., Bourgeron, T., Gillberg, C., Leboyer, M., Buxbaum, J.D., Davis, K.L., Hollander, E., Silverman, J.M., Hallmayer, J., Lotspeich, L., Sutcliffe, J.S., Haines, J.L., Folstein, S.E., Piven, J., Wassink, T.H., Sheffield, V., Geschwind, D.H., Bucan, M., Brown, W.T., Cantor, R.M., Constantino, J.N., Gilliam, T.C., Herbert, M., Lajonchere, C., Ledbetter, D.H., Lese-Martin, C., Miller, J., Nelson, S., Samango-Sprouse, C.A., Spence, S., State, M., Tanzi, R.E., Coon, H., Dawson, G., Devlin, B., Estes, A., Flodman, P., Klei, L., McMahon, W.M., Minshew, N., Munson, J., Korvatska, E., Rodier, P.M., Schellenberg, G.D., Smith, M., Spence, M.A., Stodgell, C., Tepper, P.G., Wijsman, E.M., Yu, C.E., Roge, B., Mantoulan, C., Wittemeyer, K., Poustka, A., Felder, B., Klauck, S.M., Schuster, C., Poustka, F., Bolte, S., Feineis-Matthews, S., Herbrecht, E., Schmotzer, G., Tsiantis, J., Papanikolaou, K., Maestrini, E., Bacchelli, E., Blasi, F., Carone, S., Toma, C., Van Engeland, H., de Jonge, M., Kemner, et al., Mapping autism risk loci using genetic linkage and chromosomal rearrangements. Nat. Genet. 2007, 39: 319-28.
13. Sebat, J., Lakshmi, B., Malhotra, D., Troge, J., Lese-Martin, C., Walsh, T., Yamrom, B., Yoon, S., Krasnitz, A., Kendall, J., Leotta, A., Pai, D., Zhang, R., Lee, Y.H., Hicks, J., Spence, S.J., Lee, A.T., Puura, K., Lehtimaki, T., Ledbetter, D., Gregersen, P.K., Bregman, J., Sutcliffe, J.S., Jobanputra, V., Chung, W., Warburton, D., King, M.C., Skuse, D., Geschwind, D.H., Gilliam, T.C., Ye, K., Wigler, M. Strong association of de novo copy number mutations with autism. Science 2007, 316: 445-9.
14. Jablensky, A., Sartorius, N., Korten, A., Ernberg, G., Anker, M., Cooper, J.E., Day, R. Incidence worldwide of schizophrenia. Br. J. Psychiatry 1987, 151: 408-9.
15. Kay, S.R., Opler, L.A. The positive-negative dimension in schizophrenia: its validity and significance. Psychiatr. Dev. 1987, 5: 79-103.
16. Gottesman, I. Schizophrenia genesis: The origins of madness. New York: W.H. Freeman and Company; 1991.
17. Cardno, A.G., Marshall, E.J., Coid, B., Macdonald, A.M., Ribchester, T.R., Davies, N.J., Venturi, P., Jones, L.A., Lewis, S.W., Sham, P.C., Gottesman, II, Farmer, A.E., McGuffin, P., Reveley, A.M., Murray, R.M. Heritability estimates for psychotic disorders: the Maudsley twin psychosis series. Arch. Gen. Psychiatry 1999, 56: 162-8.
18. Ross, C.A., Margolis, R.L., Reading, S.A., Pletnikov, M., Coyle, J.T. Neurobiology of schizophrenia. Neuron 2006, 52: 139-53.
19. Owen, M.J., Craddock, N., O'Donovan, M.C. Schizophrenia: genes at last? Trends Genet. 2005, 21: 518-25.
20. Lencz, T., Morgan, T.V., Athanasiou, M., Dain, B., Reed, C.R., Kane, J.M., Kucherlapati, R., Malhotra, A.K. Converging evidence for a pseudoamosomal cytokine receptor gene locus in schizophrenia. Mol. Psychiatry 2007, 12: 572-80.
21. Kato, T. Molecular genetics of bipolar disorder and depression. Psychiatry Clin. Neurosci. 2007, 61: 3-19.
22. Smoller, J.W., Finn, C.T. Family, twin, and adoption studies of bipolar disorder. Am. J. Med. Genet. C Semin. Med. Genet. 2003, 123: 48-58.
23. Berrettini, W. Evidence for shared susceptibility in bipolar disorder and schizophrenia. Am. J. Med. Genet. C Semin. Med. Genet. 2003, 123: 59-64.
24. Farmer, A., Elkin, A., McGuffin, P. The genetics of bipolar affective disorder. Curr. Opin. Psychiatry 2007, 20: 8-12.
25. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007, 447: 661-78.
26. Kessler, R.C., Berglund, P., Demler, O., Jin, R., Koretz, D., Merikangas, K.R., Rush, A.J., Walters, E.E., Wang, P.S. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 2003, 289: 3095-105.
27. Kendler, K.S., Karkowski-Shuman, L. Stressful life events and genetic liability to major depression: genetic control of exposure to the environment? Psychol. Med. 1997, 27: 539-47.
28. Massat, I., Souery, D., Del-Favero, J., Nothen, M., Blackwood, D., Muir, W., Kaneva, R., Serretti, A., Lorenzi, C., Rietschel, M., Milanova, V., Papadimitriou, G.N., Dikeos, D., Van Broekhoven, C., Mendlewicz, J. Association between COMT (Vall58Met) functional polymorphism and early onset in patients with major depressive disorder in a European multicenter genetic association study. Mol. Psychiatry 2005, 10: 598-605.
29. Caspi, A., Sugden, K., Moffitt, T.E., Taylor, A., Craig, I.W., Harrington, H., McClay, J., Mill, J., Martin, J., Braithwaite, A., Poulton, R. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 2003, 301: 386-9.
30. Schumacher, J., Jamra, R.A., Becker, T., Ohlraun, S., Klopp, N., Binder, E.B., Schulze, T.G., Deschner, M., Schmal, C., Hofels, S., Zobel, A., Illig, T., Propping, P., Holsboer, F., Rietschel, M., Nothen, M.M., Cichon, S. Evidence for a relationship between genetic variants at the brain-derived neurotrophic factor (BDNF) locus and major depression. Biol. Psychiatry 2005, 58: 307-14.
31. Surtees, P.G., Wainwright, N.W., Willis-Owen, S.A., Sandhu, M.S., Luben, R., Day, N.E., Flint, J. No association between the BDNF Val66Met polymorphism and mood status in a non-clinical community sample of 7389 older adults. J. Psychiatr. Res. 2007, 41: 404-9.
32. Gillespie, N.A., Whitfield, J.B., Williams, B., Heath, A.C., Martin, N.G. The relationship between stressful life events, the serotonin transporter (5-HTTLPR) genotype and major depression. Psychol. Med. 2005, 35: 101-11.
33. Frisch, A., Postilnick, D., Rockah, R., Michaelovsky, E., Postilnick, S., Birman, E., Laor, N., Rauchverger, B., Kreinin, A., Poyurovsky, M., Schneidman, M., Modai, I., Weizman, R. Association of unipolar major depressive disorder with genes of the serotonergic and dopaminergic pathways. Mol. Psychiatry 1999, 4: 389-92.
34. Comings, D.E. Clinical and molecular genetics of ADHD and Tourette syndrome. Two related polygenic disorders. Ann. N. Y. Acad. Sci. 2001, 931: 50-83.
35. Faraone, S.V., Sergeant, J., Gillberg, C., Biederman, J. The worldwide prevalence of ADHD: is it an American condition? World Psychiatry 2003, 2: 104-113.
36. Faraone, S.V., Khan, S.A. Candidate gene studies of attention-deficit/ hyperactivity disorder. J. Clin. Psychiatry 2006, 67 Suppl 8: 13-20.
37. Brookes, K., Xu, X., Chen, W., Zhou, K., Neale, B., Lowe, N., Anney, R., Franke, B., Gill, M., Ebstein, R., Buitelaar, J., Sham, P., Campbell, D., Knight, J., Andreou, P., Altink, M., Arnold, R., Boer, F., Buschgens, C., Butler, L., Christiansen, H., Feldman, L., Fleischman, K., Fliers, E., Howe-Forbes, R., Goldfarb, A., Heise, A., Gabriels, I., Korn-Lubetzki, I., Johansson, L., Marco, R., Medad, S., Minderaa, R., Mulas, F., Muller, U., Mulligan, A., Rabin, K., Rommelse, N., Sethna, V., Sorohan, J., Uebel, H., Psychogiou, L., Weeks, A., Barrett, R., Craig, I., Banaschewski, T., Sonuga-Barke, E., Eisenberg, J., Kuntsi, J., Manor, L, McGuffin, P., Miranda, A., Oades, R.D., Plomin, R., Roeyers, H., Rothenberger, A., Sergeant, J., Sternhausen, H.C., Taylor, E., Thompson, M., Faraone, S.V., Asherson, P. The analysis of 51 genes in DSM-IV combined type attention deficit hyperactivity disorder: association signals in DRD4, DAT1 and 16 other genes. Mol. Psychiatry 2006, 11: 934-53.
38. Robertson, M.M. Diagnosing Tourette syndrome: is it a common disorder? J. Psychosom. Res. 2003, 55: 3-6.
39. Pauls, D.L. An update on the genetics of Gilles de la Tourette syndrome. J. Psychosom. Res. 2003, 55: 7-12.
40. Grice, D.E., Leckman, J.F., Pauls, D.L., Kurlan, R., Kidd, K.K., Pakstis, A.J., Chang, F.M., Buxbaum, J.D., Cohen, D.J., Gelernter, J. Linkage disequilibrium between an allele at the dopamine D4 receptor locus and Tourette syndrome, by the transmission-disequilibrium test. Am. J. Hum. Genet. 1996, 59: 644-52.
41. Tarnok, Z., Ronai, Z., Gervai, J., Kereszturi, E., Gadoros, J., Sasvari-Szekely, M., Nemoda, Z. Dopaminergic candidate genes in Tourette syndrome: Association between tic severity and 3′ UTR polymorphism of the dopamine transporter gene. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2007, 144: 900-5.
42. Comings, D.E., Comings, B.G., Muhleman, D., Dietz, G., Shahbahrami, B., Tast, D., Knell, E., Kocsis, P., Baumgarten, R., Kovacs, B.W., Levy, D.L., Smith, M., Kane, J.M., Lieberman, J.A., KLein, D.N., MacMurray, J., Tosk, J., Sverd, J., Gysin, R., Flanagan, S. The dopamine D2 receptor locus as a modifying gene in neuropsychiatric disorders. Jama 1991, 266: 1793-800.
43. Yoon, D.Y., Rippel, C.A., Kobets, A.J., Morris, C.M., Lee, J.E., Williams, P.N., Bridges, D.D., Vandenbergh, D.J., Shugart, Y.Y., Singer, H.S. Dopaminergic polymorphisms in Tourette syndrome: association with the DAT gene (SLC6A3). Am. J. Med. Genet. B Neuropsychiatr. Genet. 2007, 144: 605-10.
44. Comings, D.E., Muhleman, D., Dietz, G., Dino, M., LeGro, R., Gade, R. Association between Tourette's syndrome and homozygosity at the dopamine D3 receptor gene. Lancet 1993, 341: 906.
45. Rowe, D.C., Stever, C., Gard, J.M., Cleveland, H.H., Sanders, M.L., Abramowitz, A., Kozol, S.T., Mohr, J.H., Sherman, S.L., Waldman, I.D. The relation of the dopamine transporter gene (DAT1) to symptoms of internalizing disorders in children. Behav. Genet. 1998, 28: 215-25.
46. Comings, D.E., Wu, S., Chiu, C., Ring, R.H., Gade, R., Ahn, C., MacMurray, J.P., Dietz, G., Muhleman, D. Polygenic inheritance of Tourette syndrome, stuttering, attention deficit hyperactivity, conduct, and oppositional defiant disorder: the additive and subtractive effect of the three dopaminergic genes - DRD2, D beta H, and DAT1. Am. J. Med. Genet. 1996, 67: 264-88.
47. Gade, R., Muhleman, D., Blake, H., MacMurray, J., Johnson, P., Verde, R., Saucier, G., Comings, D.E. Correlation of length of VNTR alleles at the X-linked MAOA gene and phenotypic effect in Tourette syndrome and drug abuse. Mol. Psychiatry 1998, 3: 50-60.
48. Gelernter, J., Pakstis, A.J., Pauls, D.L., Kurlan, R., Gancher, S.T., Civelli, O., Grandy, D., Kidd, K.K. Gilles de la Tourette syndrome is not linked to D2-dopamine receptor. Arch. Gen. Psychiatry 1990, 47: 1073-7.
49. Gelernter, J., Kennedy, J.L., Grandy, D.K., Zhou, Q.Y., Civelli, O., Pauls, D.L., Pakstis, A., Kurlan, R., Sunahara, R.K., Niznik, H.B., O'Dowd, B., Seeman, P., Kidd, K.K. Exclusion of close linkage of Tourette's syndrome to D1 dopamine receptor. Am. J. Psychiatry 1993, 150: 449-53.
50. Barr, C.L., Wigg, K.G., Zovko, E., Sandor, P., Tsui, L.C. No evidence for a major gene effect of the dopamine D4 receptor gene in the susceptibility to Gilles de la Tourette syndrome in five Canadian families. Am. J. Med. Genet. 1996, 67: 301-5.
51. Brett, P., Robertson, M., Gurling, H., Curtis, D. Failure to find linkage and increased homozygosity for the dopamine D3 receptor gene in Tourette's syndrome. Lancet 1993, 341: 1225.
52. Barr, C.L., Wigg, K.G., Zovko, E., Sandor, P., Tsui, L.C. Linkage study of the dopamine D5 receptor gene and Gilles de la Tourette syndrome. Am. J. Med. Genet. 1997, 74: 58-61.
53. Brett, P.M., Curtis, D., Robertson, M.M., Gurling, H.M. The genetic susceptibility to Gilles de la Tourette syndrome in a large multiple affected British kindred: linkage analysis excludes a role for the genes coding for dopamine D1, D2, D3, D4, D5 receptors, dopamine beta hydroxylase, tyrosinase, and tyrosine hydroxylase. Biol. Psychiatry 1995, 37: 533-40.
54. Abelson, J.F., Kwan, K.Y., O'Roak, B.J., Baek, D.Y., Stillman, A.A., Morgan, T.M., Mathews, C.A., Pauls, D.L., Rasin, M.R., Gunel, M., Davis, N.R., Ercan-Sencicek, A.G., Guez, D.H., Spertus, J.A., Leckman, J.F., Dure, L.S.t., Kurlan, R., Singer, H.S., Gilbert, D.L., Farhi, A., Louvi, A., Lifton, R.P., Sestan, N., State, M.W. Sequence variants in SLITRK1 are associated with Tourette's syndrome. Science 2005, 310: 317-20.
55. Shaywitz, S.E., Shaywitz, B.A., Fletcher, J.M., Escobar, M.D. Prevalence of reading disability in boys and girls. Results of the Connecticut Longitudinal Study. Jama 1990, 264: 998-1002.
56. Caylak, E. A review of association and linkage studies for genetical analyses of learning disorders. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2007, 144: 923-43.
57. Taipale, M., Kaminen, N., Nopola-Hemmi, J., Haltia, T., Myllyluoma, B., Lyytinen, H., Muller, K., Kaaranen, M., Lindsberg, P.J., Hannula-Jouppi, K., Kere, J. A candidate gene for developmental dyslexia encodes a nuclear tetratricopeptide repeat domain protein dynamically regulated in brain. Proc. Natl. Acad. Sci. USA 2003, 100: 11553-8.
58. Hannula-Jouppi, K., Kaminen-Ahola, N., Taipale, M., Eklund, R., Nopola-Hemmi, J., Kaariainen, H., Kere, J. The axon guidance receptor gene ROBO1 is a candidate gene for developmental dyslexia. PLoS Genet. 2005, 1: e50.
59. Meng, H., Smith, S.D., Hager, K., Held, M., Liu, J., Olson, R.K., Pennington, B.F., DeFries, J.C., Gelernter, J., O'Reilly-Pol, T., Somlo, S., Skudlarski, P., Shaywitz, S.E., Shaywitz, B.A., Marchione, K., Wang, Y., Paramasivam, M., LoTurco, J.J., Page, G.P., Gruen, J.R. DCDC2 is associated with reading disability and modulates neuronal development in the brain. Proc. Natl. Acad. Sci. USA 2005, 102: 17053-8.
60. Kjeldsen, M.J., Kyvik, K.O., Friis, M.L., Christensen, K. Genetic and environmental factors in febrile seizures: a Danish population-based twin study. Epilepsy Res. 2002, 51: 167-77.
61. Johnson, E.W., Dubovsky, J., Rich, S.S., O'Donovan, C.A., Orr, H.T., Anderson, V.E., Gil-Nagel, A., Ahmann, P., Dokken, C.G., Schneider, D.T., Weber, J.L. Evidence for a novel gene for familial febrile convulsions, FEB2, linked to chromosome 19p in an extended family from the Midwest. Hum. Mol. Genet. 1998, 7: 63-7.
62. Peiffer, A., Thompson, J., Charlier, C., Otterud, B., Varvil, T., Pappas, C., Barnitz, C., Gruenthal, K., Kuhn, R., Leppert, M. A locus for febrile seizures (FEB3) maps to chromosome 2q23-24. Ann. Neurol. 1999, 46: 671-8.
63. Nakayama, J., Hamano, K., Iwasaki, N., Nakahara, S., Horigome, Y., Saitoh, H., Aoki, T., Maki, T., Kikuchi, M., Migita, T., Ohto, T., Yokouchi, Y., Tanaka, R., Hasegawa, M., Matsui, A., Hamaguchi, H., Arinami, T. Significant evidence for linkage of febrile seizures to chromosome 5q14-q15. Hum. Mol. Genet. 2000, 9: 87-91.
64. Nakayama, J., Yamamoto, N., Hamano, K., Iwasaki, N., Ohta, M., Nakahara, S., Matsui, A., Noguchi, E., Arinami, T. Linkage and association of febrile seizures to the IMPA2 gene on human chromosome 18. Neurology 2004, 63: 1803-7.
65. Yinan, M., Yu, Q., Zhiyue, C., Jianjun, L., Lie, H., Liping, Z., Jianhui, Z., Fang, S., Dingfang, B., Qing, L., Xiru, W. Polymorphisms of casein kinase I gamma 2 gene associated with simple febrile seizures in Chinese Han population. Neurosci. Lett. 2004, 368: 2-6.
66. Feucht, M., Fuchs, K., Pichlbauer, E., Hornik, K., Scharfetter, J., Goessler, R., Fureder, T., Cvetkovic, N., Sieghart, W., Kasper, S., Aschauer, H. Possible association between childhood absence epilepsy and the gene encoding GABRB3. Biol. Psychiatry 1999, 46: 997-1002.
67. Steinlein, O., Sander, T., Stoodt, J., Kretz, R., Janz, D., Propping, P. Possible association of a silent polymorphism in the neuronal nicotinic acetylcholine receptor subunit alpha4 with common idiopathic generalized epilepsies. Am. J. Med. Genet. 1997, 74: 445-9.
68. Kanemoto, K., Kawasaki, J., Miyamoto, T., Obayashi, H., Nishimura, M. Interleukin (IL)1beta, IL-1alpha, and IL-1 receptor antagonist gene polymorphisms in patients with temporal lobe epilepsy. Ann. Neurol. 2000, 47: 571-4.
69. Tsai, F.J., Hsieh, Y.Y., Chang, C.C., Lin, C.C., Tsai, C.H. Polymorphisms for interleukin 1 beta exon 5 and interleukin 1 receptor antagonist in Taiwanese children with febrile convulsions. Arch. Pediatr. Adolesc. Med. 2002, 156: 545-8.
70. Baulac, S., Huberfeld, G., Gourfinkel-An, I., Mitropoulou, G., Beranger, A., Prud'homme, J.F., Baulac, M., Brice, A., Bruzzone, R., LeGuern, E. First genetic evidence of GABA(A) receptor dysfunction in epilepsy: a mutation in the gamma2-subunit gene. Nat. Genet. 2001, 28: 46-8.
71. Nakayama, J., Hamano, K., Noguchi, E., Horiuchi, Y., Iwasaki, N., Ohta, M., Nakahara, S., Naoi, T., Matsui, A., Arinami, T. Failure to find causal mutations in the GABA(A)-receptor gamma2 subunit (GABRG2) gene in Japanese febrile seizure patients. Neurosci. Lett. 2003, 343: 117-20.
72. Tilgen, N., Pfeiffer, H., Cobilanschi, J., Rau, B., Horvath, S., Elger, C.E., Propping, P., Heils, A. Association analysis between the human interleukin 1beta (-511) gene polymorphism and susceptibility to febrile convulsions. Neurosci. Lett. 2002, 334: 68-70.
73. Mulley, J., Heron, S., Scheffer, I., Berkovic, S. Febrile convulsions and genetic susceptibility: role of the neuronal nicotinic acetylcholine receptor alpha 4 subunit. Epilepsia 2004, 45: 561; author reply 561-2.
74. Haspolat, S., Baysal, Y., Duman, O., Coskun, M., Tosun, O., Yegin, O. Interleukin-1alpha, interleukin-1beta, and interleukin-1Ra polymorphisms in febrile seizures. J. Child Neurol. 2005, 20: 565-8.
75. Hempelmann, A., Cobilanschi, J., Heils, A., Muhle, H., Stephani, U., Weber, Y., Lerche, H., Sander, T. Lack of evidence of an allelic association of a functional GABRB3 exon 1a promoter polymorphism with idiopathic generalized epilepsy. Epilepsy Res. 2007, 74: 28-32.
76. Chelly, J., Mandel, J.L. Monogenic causes of X-linked mental retardation. Nat. Rev. Genet. 2001, 2: 669-80.
77. Batshaw, M.L. Mental retardation. Pediatr. Clin. North Am. 1993, 40: 507-21.
78. Hagberg, B., Kyllerman, M. Epidemiology of mental retardation - a Swedish survey. Brain Dev. 1983, 5: 441-9.
79. Gecz, J., Gedeon, A.K., Sutherland, G.R., Mulley, J.C. Identification of the gene FMR2, associated with FRAXE mental retardation. Nat. Genet. 1996, 13: 105-8.
80. Billuart, P., Bienvenu, T., Ronce, N., des Portes, V., Vinet, M.C., Zemni, R., Roest Crollius, H., Carrie, A., Fauchereau, F., Cherry, M., Briault, S., Hamel, B., Fryns, J.P., Beldjord, C., Kahn, A., Moraine, C., Chelly, J. Oligophrenin-1 encodes a rhoGAP protein involved in X-linked mental retardation. Nature 1998, 392: 923-6.
81. Allen, K.M., Gleeson, J.G., Bagrodia, S., Partington, M.W., Mac-Millan, J.C., Cerione, R.A., Mulley, J.C., Walsh, C.A. PAK3 mutation in nonsyndromic X-linked mental retardation. Nat. Genet. 1998, 20: 25-30.
82. D'Adamo, P., Menegon, A., Lo Nigro, C., Grasso, M., Gulisano, M., Tamanini, F., Bienvenu, T., Gedeon, A.K., Oostra, B., Wu, S.K., Tandon, A., Valtorta, F., Balch, W.E., Chelly, J., Toniolo, D. Mutations in GDI1 are responsible for X-linked non-specific mental retardation. Nat. Genet. 1998, 19: 134-9.
83. Kutsche, K., Yntema, H., Brandt, A., Jantke, I., Nothwang, H.G., Orth, U., Boavida, M.G., David, D., Chelly, J., Fryns, J.P., Moraine, C., Ropers, H.H., Hamel, B.C., van Bokhoven, H., Gal, A. Mutations in ARHGEF6, encoding a guanine nucleotide exchange factor for Rho GTPases, in patients with X-linked mental retardation. Nat. Genet. 2000, 26: 247-50.
84. Merienne, K., Jacquot, S., Pannetier, S., Zeniou, M., Bankier, A., Gecz, J., Mandel, J.L., Mulley, J., Sassone-Corsi, P., Hanauer, A. A missense mutation in RPS6KA3 (RSK2) responsible for non-specific mental retardation. Nat. Genet. 1999, 22: 13-4.
85. Carrie, A., Jun, L., Bienvenu, T., Vinet, M.C., McDonell, N., Couvert, P., Zemni, R., Cardona, A., Van Buggenhout, G., Frints, S., Hamel, B., Moraine, C., Ropers, H.H., Strom, T., Howell, G.R., Whittaker, A., Ross, M.T., Kahn, A., Fryns, J.P., Beldjord, C., Marynen, P., Chelly, J. A new member of the IL-1 receptor family highly expressed in hippocampus and involved in X-linked mental retardation. Nat. Genet. 1999, 23: 25-31.
86. Zemni, R., Bienvenu, T., Vinet, M.C., Sefiani, A., Carrie, A., Billuart, P., McDonell, N., Couvert, P., Francis, F., Chafey, P., Fauchereau, F., Friocourt, G., des Portes, V., Cardona, A., Frints, S., Meindl, A., Brandau, O., Ronce, N., Moraine, C., van Bokhoven, H., Ropers, H.H., Sudbrak, R., Kahn, A., Fryns, J.P., Beldjord, C., Chelly, J. A new gene involved in X-linked mental retardation identified by analysis of an X;2 balanced translocation. Nat. Genet. 2000, 24: 167-70.
87. Couvert, P., Bienvenu, T., Aquaviva, C., Porrier, K., Moraine, C., Gendrot, C., Verloes, A., Andres, C., Le Fevre, A.C., Souville, I., Steffann, J., des Portes, V., Ropers, H.H., Yntema, H.G., Fryns, J.P., Briault, S., Chelly, J., Cherif, B. MECP2 is highly mutated in X-linked mental retardation. Hum. Mol. Genet. 2001, 10: 941-6.
88. Meloni, I., Muscettola, M., Raynaud, M., Longo, I., Bruttini, M., Moizard, M.P., Gomot, M., Chelly, J., des Portes, V., Fryns, J.P., Ropers, H.H., Magi, B., Bellan, C., Volpi, N., Yntema, H.G., Lewis, S.E., Schaffer, J.E., Renieri, A. FACL4, encoding fatty acid-CoA ligase 4, is mutated in nonspecific X-linked mental retardation. Nat. Genet. 2002, 30: 436-40.
89. Stromme, P., Mangelsdorf, M.E., Shaw, M.A., Lower, K.M., Lewis, S.M., Bruyere, H., Lutcherath, V., Gedeon, A.K., Wallace, R.H., Scheffer, I.E., Turner, G., Partington, M., Frints, S.G., Fryns, J.P., Sutherland, G.R., Mulley, J.C., Gecz, J. Mutations in the human ortholog of Aristaless cause X-linked mental retardation and epilepsy. Nat. Genet. 2002, 30: 441-5.
90. Hiroi, N., Agatsuma, S. Genetic susceptibility to substance dependence. Mol. Psychiatry 2005, 10: 336-44.
91. Sullivan, P.F., Kendler, K.S. The genetic epidemiology of smoking. Nicotine Tob. Res. 1999, 1 Suppl 2: S51-7; discussion S69-70.
92. Guindalini, C., Howard, M., Haddley, K., Laranjeira, R., Collier, D., Ammar, N., Craig, I., O'Gara, C., Bubb, V.J., Greenwood, T., Kelsoe, J., Asherson, P., Murray, R.M., Castelo, A., Quinn, J.P., Vallada, H., Breen, G. A dopamine transporter gene functional variant associated with cocaine abuse in a Brazilian sample. Proc. Natl. Acad. Sci. USA 2006, 103: 4552-7.
93. Muramatsu, T., Higuchi, S. Dopamine transporter gene polymorphism and alcoholism. Biochem. Biophys. Res. Commun. 1995, 211: 28-32.
94. Timberlake, D.S., Haberstick, B.C., Lessem, J.M., Smolen, A., Ehringer, M., Hewitt, J.K., Hopfer, C. An association between the DAT1 polymorphism and smoking behavior in young adults from the National Longitudinal Study of Adolescent Health. Health Psychol. 2006, 25: 190-7.
95. Noble, E.P., Blum, K., Khalsa, M.E., Ritchie, T., Montgomery, A., Wood, R.C., Fitch, R.J., Ozkaragoz, T., Sheridan, P.J., Anglin, M.D., Parades, A., Treiman, L.J., Sparkes, R.S. Allelic association of the D2 dopamine receptor gene with cocaine dependence. Drug Alcohol Depend. 1993, 33: 271-85.
96. Blum, K., Noble, E.P., Sheridan, P.J., Montgomery, A., Ritchie, T., Jagadeeswaran, P., Nogami, H., Briggs, A.H., Cohn, J.B. Allelic association of human dopamine D2 receptor gene in alcoholism. JAMA 1990, 263: 2055-60.
97. Xu, K., Lichtermann, D., Lipsky, R.H., Franke, P., Liu, X., Hu, Y., Cao, L., Schwab, S.G., Wildenauer, D.B., Bau, C.H., Ferro, E., Astor, W., Finch, T., Terry, J., Taubman, J., Maier, W., Goldman, D. Association of specific haplotypes of D2 dopamine receptor gene with vulnerability to heroin dependence in 2 distinct populations. Arch. Gen. Psychiatry 2004, 61: 597-606.
98. Duaux, E., Gorwood, P., Griffon, N., Bourdel, M.C., Sautel, F., Sokoloff, P., Schwartz, J.C., Ades, J., Loo, H., Porrier, M.F. Homozygosity at the dopamine D3 receptor gene is associated with opiate dependence. Mol. Psychiatry 1998, 3: 333-6.
99. Comings, D.E., Gonzalez, N., Wu, S., Saucier, G., Johnson, P., Verde, R., MacMurray, J.P. Homozygosity at the dopamine DRD3 receptor gene in cocaine dependence. Mol. Psychiatry 1999, 4: 484-7.
100. Tiihonen, J., Hallikamen, T., Lachman, H., Saito, T., Volavka, J., Kauhanen, J., Salonen, J.T., Ryynanen, O.P., Koulu, M., Karvonen, M.K., Pohjalainen, T., Syvalahti, E., Hietala, J. Association between the functional variant of the catechol-O-methyltransferase (COMT) gene and type 1 alcoholism. Mol. Psychiatry 1999, 4: 286-9.
101. Horowitz, R., Kotler, M., Shufman, E., Aharoni, S., Kremer, I., Cohen, H., Ebstein, R.P. Confirmation of an excess of the high enzyme activity COMT val allele in heroin addicts in a family-based haplotype relative risk study. Am. J. Med. Genet. 2000, 96: 599-603.
102. Munafo, M., Clark, T., Johnstone, E., Murphy, M., Walton, R. The genetic basis for smoking behavior: a systematic review and meta-analysis. Nicotine Tob. Res. 2004, 6: 583-97.
103. Munafo, M.R., Matheson, I.J., Flint, J. Association of the DRD2 gene Taq1A polymorphism and alcoholism: a meta-analysis of case-control studies and evidence of publication bias. Mol. Psychiatry 2007, 12: 454-61.
104. Green, R.F., Stoler, J.M. Alcohol dehydrogenase 1B genotype and fetal alcohol syndrome: a HuGE minireview. Am. J. Obstet. Gynecol. 2007, 197: 12-25.
105. Rasheed, A., Hines, R.N., McCarver-May, D.G. Variation in induction of human placental CYP2E1: possible role in susceptibility to fetal alcohol syndrome? Toxicol. Appl. Pharmacol. 1997, 144: 396-400.
106. Boutelet-Bochan, H., Huang, Y., Juchau, M.R. Expression of CYP2E1 during embryogenesis and fetogenesis in human cephalic tissues: implications for the fetal alcohol syndrome. Biochem. Biophys. Res. Commun. 1997, 238: 443-7.
107. Kessler, R.C., McGonagle, K.A., Zhao, S., Nelson, C.B., Hughes, M., Eshleman, S., Wittchen, H.U., Kendler, K.S. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch. Gen. Psychiatry 1994, 51: 8-19.
108. Hettema, J.M., Neale, M.C., Kendler, K.S. A review and meta-analysis of the genetic epidemiology of anxiety disorders. Am. J. Psychiatry 2001, 158: 1568-78.
109. Hamilton, S.P., Fyer, A.J., Durner, M., Heiman, G.A., Baisre de Leon, A., Hodge, S.E., Knowles, J.A., Weissman, M.M. Further genetic evidence for a panic disorder syndrome mapping to chromosome 13q. Proc. Natl. Acad. Sci. USA 2003, 100: 2550-5.
110. Thorgeirsson, T.E., Oskarsson, H., Desnica, N., Kostic, J.P., Stefansson, J.G., Kolbeinsson, H., Lindal, E., Gagunashvili, N., Frigge, M.L., Kong, A., Stefansson, K., Gulcher, J.R. Anxiety with panic disorder linked to chromosome 9q in Iceland. Am. J. Hum. Genet. 2003, 72: 1221-30.
111. Hanna, G.L., Veenstra-Vanderweele, J., Cox, N.J., Van Etten, M., Fischer, D.J., Himle, J.A., Bivens, N.C., Wu, X., Roe, C.A., Hennessy, K.A., Dickel, D.E., Leventhal, B.L., Cook, E.H. Jr. Evidence for a susceptibility locus on chromosome 10p15 in early-onset obsessive-compulsive disorder. Biol. Psychiatry 2007, 62: 856-62.
112. Hanna, G.L., Veenstra-VanderWeele, J., Cox, N.J., Boehnke, M., Himle, J.A., Curtis, G.C., Leventhal, B.L., Cook, E.H., Jr. Genome-wide linkage analysis of families with obsessive-compulsive disorder ascertained through pediatric probands. Am. J. Med. Genet. 2002, 114: 541-52.
113. Samuels, J., Shugart, Y.Y., Grados, M.A., Willour, V.L., Bienvenu, O.J., Greenberg, B.D., Knowles, J.A., McCracken, J.T., Rauch, S.L., Murphy, D.L., Wang, Y., Pinto, A., Fyer, A.J., Piacentini, J., Pauls, D.L., Cullen, B., Rasmussen, S.A., Hoehn-Saric, R., Valle, D., Liang, K.Y., Riddle, M.A., Nestadt, G. Significant linkage to compulsive hoarding on chromosome 14 in families with obsessive-compulsive disorder: results from the OCD Collaborative Genetics Study. Am. J. Psychiatry 2007, 164: 493-9.
114. Shugart, Y.Y., Samuels, J., Willour, V.L., Grados, M.A., Greenberg, B.D., Knowles, J.A., McCracken, J.T., Rauch, S.L., Murphy, D.L., Wang, Y., Pinto, A., Fyer, A.J., Piacentini, J., Pauls, D.L., Cullen, B., Page, J., Rasmussen, S.A., Bienvenu, O.J., Hoehn-Saric, R., Valle, D., Liang, K.Y., Riddle, M.A., Nestadt, G. Genomewide linkage scan for obsessive-compulsive disorder: evidence for susceptibility loci on chromosomes 3q, 7p, 1q, 15q, and 6q. Mol. Psychiatry 2006, 11: 763-70.
115. Gelernter, J., Page, G.P., Bonvicini, K., Woods, S.W., Pauls, D.L., Kruger, S. A chromosome 14 risk locus for simple phobia: results from a genomewide linkage scan. Mol. Psychiatry 2003, 8: 71-82.
116. Gelernter, J., Page, G.P., Stein, M.B., Woods, S.W. Genome-wide linkage scan for loci predisposing to social phobia: evidence for a chromosome 16 risk locus. Am. J. Psychiatry 2004, 161: 59-66.
117. Fullerton, J., Cubin, M., Tiwari, H., Wang, C., Bomhra, A., Davidson, S., Miller, S., Fairburn, C., Goodwin, G., Neale, M.C., Fiddy, S., Mott, R., Allison, D.B., Flint, J. Linkage analysis of extremely discordant and concordant sibling pairs identifies quantitative-trait loci that influence variation in the human personality trait neuroticism. Am. J. Hum. Genet. 2003, 72: 879-90.
118. Cloninger, C.R., Van Eerdewegh, P., Goate, A., Edenberg, H.J., Blangero, J., Hesselbrock, V., Reich, T., Nurnberger, J., Jr., Schuckit, M., Porjesz, B., Crowe, R., Rice, J.P., Foroud, T., Przybeck, T.R., Almasy, L., Bucholz, K., Wu, W., Shears, S., Carr, K., Crose, C., Willig, C., Zhao, J., Tischfield, J.A., Li, T.K., Conneally, P.M., Begleiter, H. Anxiety proneness linked to epistatic loci in genome scan of human personality traits. Am. J. Med. Genet. 1998, 81: 313-7.
119. Middeldorp, C.M., Hottenga, J.J., Slagboom, P.E., Sullivan, P.F., de Geus, E.J., Posthuma, D., Willemsen, G., Boomsma, D.I. Linkage on chromosome 14 in a genome-wide linkage study of a broad anxiety phenotype. Mol. Psychiatry 2008, 13: 84-9.
120. Kaabi, B., Gelernter, J., Woods, S.W., Goddard, A., Page, G.P., Elston, R.C. Genome scan for loci predisposing to anxiety disorders using a novel multivariate approach: strong evidence for a chromosome 4 risk locus. Am. J. Hum. Genet. 2006, 78: 543-53.
121. Rothe, C., Gutknecht, L., Freitag, C., Tauber, R., Mossner, R., Franke, P., Fritze, J., Wagner, G., Peikert, G., Wenda, B., Sand, P., Jacob, C., Rietschel, M., Nothen, M.M., Garritsen, H., Fimmers, R., Deckert, J., Lesch, K.P. Association of a functional 1019C>G 5-HT1A receptor gene polymorphism with panic disorder with agoraphobia. Int. J. Neuropsychopharmacol. 2004, 7: 189-92.
122. Inada, Y., Yoneda, H., Koh, J., Sakai, J., Himei, A., Kinoshita, Y., Akabame, K., Hiraoka, Y., Sakai, T. Positive association between panic disorder and polymorphism of the serotonin 2A receptor gene. Psychiatry Res. 2003, 118: 25-31.
123. Domschke, K., Freitag, C.M., Kuhlenbaumer, G., Schirmacher, A., Sand, P., Nyhuis, P., Jacob, C., Fritze, J., Franke, P., Rietschel, M., Garritsen, H.S., Fimmers, R., Nothen, M.M., Lesch, K.P., Stogbauer, F., Deckert, J. Association of the functional V158M catechol-O-methyl-transferase polymorphism with panic disorder in women. Int. J. Neuropsychopharmacol. 2004, 7: 183-8.
124. Miyasaka, K., Yoshida, Y., Matsushita, S., Higuchi, S., Shirakawa, O., Shimokata, H., Funakoshi, A. Association of cholecystokinin-A receptor gene polymorphisms and panic disorder in Japanese. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2004, 127: 78-80.
125. Deckert, J., Nothen, M.M., Franke, P., Delmo, C., Fritze, J., Knapp, M., Maier, W., Beckmann, H., Propping, P. Systematic mutation screening and association study of the A1 and A2a adenosine receptor genes in panic disorder suggest a contribution of the A2a gene to the development of disease. Mol. Psychiatry 1998, 3: 81-5.
126. Deckert, J., Catalano, M., Syagailo, Y.V., Bosi, M., Okladnova, O., Di Bella, D., Nothen, M.M., Maffei, P., Franke, P., Fritze, J., Maier, W., Propping, P., Beckmann, H., Bellodi, L., Lesch, K.P. Excess of high activity monoamine oxidase A gene promoter alleles in female patients with panic disorder. Hum. Mol. Genet. 1999, 8: 621-4.
127. Domschke, K., Kuhlenbaumer, G., Schirmacher, A., Lorenzi, C., Armengol, L., DiBella, D., Gratacos, M., Garritsen, H.S., Nothen, M.M., Franke, P., Sand, P., Fritze, J., Perez, G., Maier, W., Sibrowski, W., Estivill, X., Bellodi, L., Ringelstein, E.B., Arolt, V., Martin-Santos, R., Catalano, M., Stogbauer, F., Deckert, J. Human nuclear transcription factor gene CREM: genomic organization, mutation screening, and association analysis in panic disorder. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2003, 117: 70-8.
128. Nakamura, K., Yamada, K., Iwayama, Y., Toyota, T., Furukawa, A., Takimoto, T., Terayama, H., Iwahashi, K., Takei, N., Minabe, Y., Sekine, Y., Suzuki, K., Iwata, Y., Pillai, A., Nakamoto, Y., Ikeda, K., Yoshii, M., Fukunishi, I., Yoshikawa, T., Mori, N. Evidence that variation in the peripheral benzodiazepine receptor (PBR) gene influences susceptibility to panic disorder. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2006, 141: 222-6.
129. Hettema, J.M., An, S.S., Neale, M.C., Bukszar, J., van den Oord, E.J., Kendler, K.S., Chen, X. Association between glutamic acid decarboxylase genes and anxiety disorders, major depression, and neuroticism. Mol. Psychiatry 2006, 11: 752-62.
130. Thoeringer, C.K., Binder, E.B., Salyakina, D., Erhardt, A., Ising, M., Unschuld, P.G., Kern, N., Lucae, S., Brueckl, T.M., Mueller, M.B., Fuchs, B., Puetz, B., Lieb, R., Uhr, M., Holsboer, F., Mueller-Myhsok, B., Keck, M.E. Association of a Met88Val diazepam binding inhibitor (DBI) gene polymorphism and anxiety disorders with panic attacks. J. Psychiatr. Res. 2007, 41: 579-84.
131. Erhardt, A., Lucae, S., Unschuld, P.G., Ising, M., Kern, N., Salyakina, D., Lieb, R., Uhr, M., Binder, E.B., Keck, M.E., Muller-Myhsok, B., Holsboer, F. Association of polymorphisms in P2RX7 and CaMKKb with anxiety disorders. J. Affect. Disord. 2007, 101: 159-68.
132. Olsson, M., Annerbrink, K., Westberg, L., Melke, J., Baghaei, F., Rosmond, R., Holm, G., Andersch, S., Allgulander, C., Eriksson, E. Angiotensin-related genes in patients with panic disorder. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2004, 127: 81-4.
133. Maron, E., Nikopensius, T., Koks, S., Altmae, S., Heinaste, E., Vabrit, K., Tammekivi, V., Hallast, P., Koido, K., Kurg, A., Metspalu, A., Vasar, E., Vasar, V., Shlik, J. Association study of 90 candidate gene polymorphisms in panic disorder. Psychiatr. Genet. 2005, 15: 17-24.
134. Camarena, B., Aguilar, A., Loyzaga, C., Nicolini, H. A family-based association study of the 5-HT-1Dbeta receptor gene in obsessive-compulsive disorder. Int. J. Neuropsychopharmacol. 2004, 7: 49-53.
135. Lochner, C., Hemmings, S.M., Kinnear, C.J., Moolman-Smook, J.C., Corfield, V.A., Knowles, J.A., Niehaus, D.J., Stein, D.J. Gender in obsessive-compulsive disorder: clinical and genetic findings. Eur. Neuropsychopharmacol. 2004, 14: 105-13.
136. Meira-Lima, I., Shavitt, R.G., Miguita, K., Ikenaga, E., Miguel, E.C., Vallada, H. Association analysis of the catechol-o-methyltransferase (COMT), serotonin transporter (5-HTT) and serotonin 2A receptor (5HT2A) gene polymorphisms with obsessive-compulsive disorder. Genes Brain Behav. 2004, 3: 75-9.
137. Lesch, K.P., Bengel, D., Heils, A., Sabol, S.Z., Greenberg, B.D., Petri, S., Benjamin, J., Muller, C.R., Hamer, D.H., Murphy, D.L. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 1996, 274: 1527-31.
138. Schinka, J.A., Busch, R.M., Robichaux-Keene, N. A meta-analysis of the association between the serotonin transporter gene polymorphism (5-HTTLPR) and trait anxiety. Mol. Psychiatry 2004, 9: 197-202.
139. Sen, S., Burmeister, M., Ghosh, D. Meta-analysis of the association between a serotonin transporter promoter polymorphism (5-HTTLPR) and anxiety-related personality traits. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2004, 127: 85-9.
140. Tadic, A., Rujescu, D., Szegedi, A., Giegling, I., Singer, P., Moller, H.J., Dahmen, N. Association of a MAOA gene variant with generalized anxiety disorder, but not with panic disorder or major depression. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2003, 117: 1-6.
141. Eley, T.C., Tahir, E., Angleitner, A., Harriss, K., McClay, J., Plomin, R., Riemann, R., Spinath, F., Craig, I. Association analysis of MAOA and COMT with neuroticism assessed by peers. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2003, 120: 90-6.
142. McGrath, M., Kawachi, I., Ascherio, A., Colditz, G.A., Hunter, D.J., De Vivo, I. Association between catechol-O-methyltransferase and phobic anxiety. Am. J. Psychiatry 2004, 161: 1703-5.
143. Hunnerkopf R., Strobel, A., Gutknecht, L., Brocke, B., Lesch, K.P. Interaction between BDNF Val66Met and dopamine transporter gene variation influences anxiety-related traits. Neuropsychopharmacology 2007, 32: 2552-60.
144. Lang, U.E., Hellweg, R., Kalus, P., Bajbouj, M., Lenzen, K.P., Sander, T., Kunz, D., Gallinat, J. Association of a functional BDNF polymorphism and anxiety-related personality traits. Psychopharmacology (Berl) 2005, 180: 95-9.
145. Nemeroff, C.B., Bremner, J.D., Foa, E.B., Mayberg, H.S., North, C.S., Stein, M.B. Posttraumatic stress disorder: a state-of-the-science review. J. Psychiatr. Res. 2006, 40: 1-21.
146. Breslau, N., Kessler, R.C., Chilcoat, H.D., Schultz, L.R., Davis, G.C., Andreski, P. Trauma and posttraumatic stress disorder in the community: the 1996 Detroit Area Survey of Trauma. Arch. Gen. Psychiatry 1998, 55: 626-32.
147. Kessler, R.C., Sonnega, A., Bromet, E., Hughes, M., Nelson, C.B. Posttraumatic stress disorder in the National Comorbidity Survey. Arch. Gen. Psychiatry 1995, 52: 1048-60.
148. True, W.R., Rice, J., Eisen, S.A., Heath, A.C., Goldberg, J., Lyons, M.J., Nowak, J. A twin study of genetic and environmental contributions to liability for posttraumatic stress symptoms. Arch. Gen. Psychiatry 1993, 50: 257-64.
149. Zhang, H., Ozbay, F., Lappalainen, J., Kranzler, H.R., van Dyck, C.H., Charney, D.S., Price, L.H., Southwick, S., Yang, B.Z., Rasmussen, A., Gelernter, J. Brain derived neurotrophic factor (BDNF) gene variants and Alzheimer's disease, affective disorders, posttraumatic stress disorder, schizophrenia, and substance dependence. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2006, 141: 387-93.
150. Lappalainen, J., Kranzler, H.R., Malison, R., Price, L.H., Van Dyck, C., Rosenheck, R.A., Cramer, J., Southwick, S., Charney, D., Krystal, J., Gelernter, J. A functional neuropeptide Y Leu7Pro polymorphism associated with alcohol dependence in a large population sample from the United States. Arch. Gen. Psychiatry 2002, 59: 825-31.
151. Bachmann, A.W., Sedgley, T.L., Jackson, R.V., Gibson, J.N., Young, R.M., Torpy, D.J. Glucocorticoid receptor polymorphisms and post-traumatic stress disorder. Psychoneuroendocrinology 2005, 30: 297-306.
152. Lee, H.J., Lee, M.S., Kang, R.H., Kim, H., Kim, S.D., Kee, B.S., Kim, Y.H., Kim, Y.K., Kim, J.B., Yeon, B.K., Oh, K.S., Oh, B.H., Yoon, J.S., Lee, C., Jung, H.Y., Chee, I.S., Paik, I.H. Influence of the serotonin transporter promoter gene polymorphism on susceptibility to posttraumatic stress disorder. Depress. Anxiety 2005, 21: 135-9.
153. Comings, D.E., Muhleman, D., Gysin, R. Dopamine D2 receptor (DRD2) gene and susceptibility to posttraumatic stress disorder: a study and replication. Biol. Psychiatry 1996, 40: 368-72.
154. Bulik, C.M., Sullivan, P.F., Kendler, K.S. Heritability of binge-eating and broadly defined bulimia nervosa. Biol. Psychiatry 1998, 44: 1210-8.
155. Klump, K.L., Miller, K.B., Keel, P.K., McGue, M., Iacono, W.G. Genetic and environmental influences on anorexia nervosa syndromes in a population-based twin sample. Psychol. Med. 2001, 31: 737-40.
156. Kortegaard, L.S., Hoerder, K., Joergensen, J., Gillberg, C., Kyvik, K.O. A preliminary population-based twin study of self-reported eating disorder. Psychol. Med. 2001, 31: 361-5.
157. Kendler, K.S., MacLean, C., Neale, M., Kessler, R., Heath, A., Eaves, L. The genetic epidemiology of bulimia nervosa. Am. J. Psychiatry 1991, 148: 1627-37.
158. Collier, D.A., Arranz, M.J., Li, T., Mupita, D., Brown, N., Treasure, J. Association between 5-HT2A gene promoter polymorphism and anorexia nervosa. Lancet 1997, 350: 412.
159. Westberg, L., Bah, J., Rastam, M., Gillberg, C., Wentz, E., Melke, J., Hellstrand, M., Eriksson, E. Association between a polymorphism of the 5-HT2C receptor and weight loss in teenage girls. Neuropsychopharmacology 2002, 26: 789-93.
160. Di Bella, D.D., Catalano, M., Cavallini, M.C., Riboldi, C., Bellodi, L. Serotonin transporter linked polymorphic region in anorexia nervosa and bulimia nervosa. Mol. Psychiatry 2000, 5: 233-4.
161. Campbell, D.A., Sundaramurthy, D., Markham, A.F., Pieri, L.F. Lack of association between 5-HT2A gene promoter polymorphism and susceptibility to anorexia nervosa. Lancet 1998, 351: 499.
162. Burnet, P.W., Smith, K.A., Cowen, P.J., Fairburn, C.G., Harrison, P.J. Allelic variation of the 5-HT2C receptor (HTR2C) in bulimia nervosa and binge eating disorder. Psychiatr. Genet. 1999, 9: 101-4.
163. Koizumi, H., Hashimoto, K., Itoh, K., Nakazato, M., Shimizu, E., Ohgake, S., Koike, K., Okamura, N., Matsushita, S., Suzuki, K., Murayama, M., Higuchi, S., Iyo, M. Association between the brain-derived neurotrophic factor 196G/A polymorphism and eating disorders. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2004, 127: 125-7.
164. Ribases, M., Gratacos, M., Fernandez-Aranda, F., Bellodi, L., Boni, C., Anderluh, M., Cavallini, M.C., Cellini, E., Di Bella, D., Erzegovesi, S., Foulon, C., Gabrovsek, M., Gorwood, P., Hebebrand, J., Hinney, A., Holliday, J., Hu, X., Karwautz, A., Kipman, A., Komel, R., Nacmias, B., Remschmidt, H., Ricca, V., Sorbi, S., Wagner, G., Treasure, J., Collier, D.A., Estivill, X. Association of BDNF with anorexia, bulimia and age of onset of weight loss in six European populations. Hum. Mol. Genet. 2004, 13: 1205-12.
165. Miyasaka, K., Hosoya, H., Sekime, A., Ohta, M., Amono, H., Matsushita, S., Suzuki, K., Higuchi, S., Funakoshi, A. Association of ghrelin receptor gene polymorphism with bulimia nervosa in a Japanese population. J. Neural Transm. 2006, 113: 1279-85.
166. Frieling, H., Romer, K.D., Wilhelm, J., Hillemacher, T., Kornhuber, J., de Zwaan, M., Jacoby, G.E., Bleich, S. Association of catecholamine-O-methyltransferase and 5-HTTLPR genotype with eating disorder-related behavior and attitudes in females with eating disorders. Psychiatr. Genet. 2006, 16: 205-8.
167. Mikolajczyk, E., Smiarowska, M., Grzywacz, A., Samochowiec, J. Association of eating disorders with catechol-o-methyltransferase gene functional polymorphism. Neuropsychobiology 2006, 54: 82-6.
168. Frey, L., Hauser, W.A. Epidemiology of neural tube defects. Epilepsia 2003, 44 Suppl 3: 4-13.
169. Padmanabhan, R. Etiology, pathogenesis and prevention of neural tube defects. Congenit. Anom. (Kyoto) 2006, 46: 55-67.
170. Whitehead, A.S., Gallagher, P., Mills, J.L., Kirke, P.N., Burke, H., Molloy, A.M., Weir, D.G., Shields, D.C., Scott, J.M. A genetic defect in 5,10 methylenetetrahydrofolate reductase in neural tube defects. Qjm 1995, 88: 763-6.
171. van der Linden, I.J., den Heijer, M., Afman, L.A., Gellekink, H., Vermeulen, S.H., Kluijtmans, L.A., Blom, H.J. The methionine synthase reductase 66A>G polymorphism is a maternal risk factor for spina bifida. J. Mol. Med. 2006, 84: 1047-54.
172. Zhu, H., Wicker, N.J., Volcik, K., Zhang, J., Shaw, G.M., Lammer, E.J., Suarez, L., Canfield, M., Finnell, R.H. Promoter haplotype combinations for the human PDGFRA gene are associated with risk of neural tube defects. Mol. Genet. Metab. 2004, 81: 127-32.
173. Brown, K.S., Cook, M., Hoess, K., Whitehead, A.S., Mitchell, L.E. Evidence that the risk of spina bifida is influenced by genetic variation at the NOS3 locus. Birth Defects Res. A Clin. Mol. Teratol. 2004, 70: 101-6.
174. Zhu, H., Yang, W., Lu, W., Zhang, J., Shaw, G.M., Lammer, E.J., Finnell, R.H. A known functional polymorphism (Ile 120Val) of the human PCMT1 gene and risk of spina bifida. Mol. Genet. Metab. 2006, 87: 66-70.
175. Zhu, H., Enaw, J.O., Ma, C., Shaw, G.M., Lammer, E.J., Finnell, R.H. Association between CFL1 gene polymorphisms and spina bifida risk in a California population. BMC Med. Genet. 2007, 8: 12.
176. Fernell, E., Hagberg, B., Hagberg, G., von Wendt, L. Epidemiology of infantile hydrocephalus in Sweden. I. Birth prevalence and general data. Acta Paediatr. Scand. 1986, 75: 975-81.
177. Halliday, J., Chow, CW., Wallace, D., Danks, D.M. X linked hydrocephalus: a survey of a 20 year period in Victoria, Australia. J. Med. Genet. 1986, 23: 23-31.
178. Willems, P.J. Heterogeneity in familial hydrocephalus. Am. J. Med. Genet. 1988, 31: 471-3.
179. Stoll, C., Alembik, Y., Dott, B., Roth, M.P. An epidemiologic study of environmental and genetic factors in congenital hydrocephalus. Eur. J. Epidemiol. 1992, 8: 797-803.
180. Haverkamp, F., Wolfle, J., Aretz, M., Kramer, A., Hohmann, B., Fahnenstich, H., Zerres, K. Congenital hydrocephalus internus and aqueduct stenosis: aetiology and implications for genetic counselling. Eur. J. Pediatr. 1999, 158: 474-8.
181. Zhang, J., Williams, M.A., Rigamonti, D. Genetics of human hydrocephalus. J. Neurol. 2006, 253: 1255-66.
182. Schroeder, S.R. Mental retardation and developmental disabilities influenced by environmental neurotoxic insults. Environ. Health Perspect. 2000, 108 Suppl 3: 395-9.
183. Fatemi, S.H., Earle, J., Kanodia, R., Kist, D., Emamian, E.S., Patterson, P.H., Shi, L., Sidwell, R. Prenatal viral infection leads to pyramidal cell atrophy and macrocephaly in adulthood: implications for genesis of autism and schizophrenia. Cell. Mol. Neurobiol. 2002, 22: 25-33.
184. Boog, G. Obstetrical complications and subsequent schizophrenia in adolescent and young adult offsprings: is there a relationship? Eur. J. Obstet. Gynecol. Reprod. Biol. 2004, 114: 130-6.
185. Curatolo, P., Arpino, C., Stazi, M.A., Medda, E. Risk factors for the co-occurrence of partial epilepsy, cerebral palsy and mental retardation. Dev. Med. Child Neurol. 1995, 37: 776-82.
186. Torrey, E.F., Rawlings, R.R., Ennis, J.M., Merrill, D.D., Flores, D.S. Birth seasonality in bipolar disorder, schizophrenia, schizoaffective disorder and stillbirths. Schizophr. Res. 1996, 21: 141-9.
187. Torrey, E.F., Miller, J., Rawlings, R., Yolken, R.H. Seasonality of births in schizophrenia and bipolar disorder: a review of the literature. Schizophr. Res. 1997, 28: 1-38.
188. Mortensen, P.B., Pedersen, C.B., Westergaard, T., Wohlfahrt, J., Ewald, H., Mors, O., Andersen, P.K., Melbye, M. Effects of family history and place and season of birth on the risk of schizophrenia. N. Engl. J. Med. 1999, 340: 603-8.
189. Yearwood, E.L., Crawford, S., Kelly, M., Moreno, N. Immigrant youth at risk for disorders of mood: recognizing complex dynamics. Arch. Psychiatr. Nurs. 2007, 21: 162-71.
190. Cantor-Graae, E., Pedersen, C.B. Risk for schizophrenia in intercountry adoptees: a Danish population-based cohort study. J. Child Psychol. Psychiatry 2007, 48: 1053-60.
191. Caspi, A., Moffitt, T.E., Cannon, M., McClay, J., Murray, R., Harrington, H., Taylor, A., Arseneault, L., Williams, B., Braithwaite, A., Poulton, R., Craig, I.W. Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene X environment interaction. Biol. Psychiatry 2005, 57: 1117-27.
192. Wolffe, A.P., Matzke, M.A. Epigenetics: regulation through repression. Science 1999, 286: 481-6.
193. Reik, W., Romer, L, Barton, S.C., Surani, M.A., Howlett, S.K., Klose, J. Adult phenotype in the mouse can be affected by epigenetic events in the early embryo. Development 1993, 119: 933-42.
194. Rideout, W.M., 3rd, Eggan, K., Jaenisch, R. Nuclear cloning and epigenetic reprogramming of the genome. Science 2001, 293: 1093-8.
195. Amir, R.E., Van den Veyver, I.B., Wan, M., Tran, C.Q., Francke, U., Zoghbi, H.Y. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat. Genet. 1999, 23: 185-8.
196. Xu, G.L., Bestor, T.H., Bourc'his, D., Hsieh, C.L., Tommerup, N., Bugge, M., Hulten, M., Qu, X., Russo, J.J., Viegas-Pequignot, E. Chromosome instability and immunodeficiency syndrome caused by mutations in a DNA methyltransferase gene. Nature 1999, 402: 187-91.
197. Gibbons, R.J., McDowell, T.L., Raman, S., O'Rourke, D.M., Garrick, D., Ayyub, H., Higgs, D.R. Mutations in ATRX, encoding a SWI/SNF-like protein, cause diverse changes in the pattern of DNA methylation. Nat. Genet. 2000, 24: 368-71.
198. Jin, P., Warren, S.T. Understanding the molecular basis of fragile X syndrome. Hum. Mol. Genet. 2000, 9: 901-8.
199. Pitkin, R.M. Folate and neural tube defects. Am. J. Clin. Nutr. 2007, 85: 285S-288S.
200. Herran, A., Garcia-Unzueta, M.T., Amado, J.A., Lopez-Cordovilla, J.J., Diez-Manrique, J.F., Vazquez-Barquero, J.L. Folate levels in psychiatric outpatients. Psychiatry Clin. Neurosci. 1999, 53: 531-3.
201. Tremolizzo, L., Carboni, G., Ruzicka, W.B., Mitchell, C.P., Sugaya, I., Tueting, P., Sharma, R., Grayson, D.R., Costa, E., Guidotti, A. An epigenetic mouse model for molecular and behavioral neuropathologies related to schizophrenia vulnerability. Proc. Natl. Acad. Sci. USA 2002, 99: 17095-100.
202. Weaver, I.C., Cervoni, N., Champagne, F.A., D'Alessio, A.C., Sharma, S., Seckl, J.R., Dymov, S., Szyf, M., Meaney, M.J. Epigenetic programming by maternal behavior. Nat. Neurosci. 2004, 7: 847-54.
203. Gottesman, II, Gould, T.D. The endophenotype concept in psychiatry: etymology and strategic intentions. Am. J. Psychiatry 2003, 160: 636-45.
204. Flint, J., Munafo, M.R. The endophenotype concept in psychiatric genetics. Psychol. Med. 2007, 37: 163-80.
205. Risch, N. Linkage strategies for genetically complex traits. I. Multilocus models. Am. J. Hum. Genet. 1990, 46: 222-8.
206. Peng, B., Kimmel, M. Simulations provide support for the common disease-common variant hypothesis. Genetics 2007, 175: 763-76.
207. Reich, D.E., Lander, E.S. On the allelic spectrum of human disease. Trends Genet. 2001, 17: 502-10.
208. Pritchard, J.K. Are rare variants responsible for susceptibility to complex diseases? Am. J. Hum. Genet. 2001, 69: 124-37.
209. Slager, S.L., Huang, J., Vieland, V.J. Effect of allelic heterogeneity on the power of the transmission disequilibrium test. Genet. Epidemiol. 2000, 18: 143-56.
210. Wollstein, A., Herrmann, A., Wittig, M., Nothnagel, M., Franke, A., Nurnberg, P., Schreiber, S., Krawczak, M., Hampe, J. Efficacy assessment of SNP sets for genome-wide disease association studies. Nucleic Acids Res. 2007, 35: e113.
211. Cargill, M., Altshuler, D., Ireland, J., Sklar, P., Ardlie, K., Patil, N., Shaw, N., Lane, C.R., Lim, E.P., Kalyanaraman, N., Nemesh, J., Ziaugra, L., Friedland, L., Rolfe, A., Warrington, J., Lipshutz, R., Daley, G.Q., Lander, E. S. Characterization of single-nucleotide polymorphisms in coding regions of human genes. Nat. Genet. 1999, 22: 231-8.
212. Jorde, L.B., Fineman, R.M., Martin, R.A. Epidemiology and genetics of neural tube defects: an application of the Utah Genealogical Data Base. Am. J. Phys. Anthropol. 1983, 62: 23-31.
213. Hawke, J.L., Wadsworth, S.J., DeFries, J.C. Genetic influences on reading difficulties in boys and girls: the Colorado twin study. Dyslexia 2006, 12: 21-9.
214. Fyer, A.J., Hamilton, S.P., Durner, M., Haghighi, F., Heiman, G.A., Costa, R., Evgrafov, O., Adams, P., de Leon, A.B., Taveras, N., Klein, D.E., Hodge, S.E., Weissman, M.M., Knowles, J.A. A third-pass genome scan in panic disorder: evidence for multiple susceptibility loci. Biol. Psychiatry 2006, 60: 388-401.
215. Clifford, C.A., Murray, R.M., Fulker, D.W. Genetic and environmental influences on obsessional traits and symptoms. Psychol. Med. 1984, 14: 791-800.
216. Jonnal, A.H., Gardner, C.O., Prescott, C.A., Kendler, K.S. Obsessive and compulsive symptoms in a general population sample of female twins. Am. J. Med. Genet. 2000, 96: 791-6.